P/E ratio for Biolase (BIOL)
P/E ratio as of April 2025 (TTM): 0.0000
According to Biolase 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.5295E-5. At the end of 2022 the company had a P/E ratio of -0.1582.
P/E ratio history for Biolase from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.1582 | -95.66% |
| 2021 | -3.65 | 416.11% |
| 2020 | -0.7063 | 0.95% |
| 2019 | -0.6996 | -25.8% |
| 2018 | -0.9429 | -37.2% |
| 2017 | -1.50 | -68.9% |
| 2016 | -4.83 | 95.15% |
| 2015 | -2.47 | -56.73% |
| 2014 | -5.72 | -31.03% |
| 2013 | -8.29 | -54.68% |
| 2012 | -18.3 | 18.55% |
| 2011 | -15.4 | 334.11% |
| 2010 | -3.55 | -79.53% |
| 2009 | -17.4 | 342.83% |
| 2008 | -3.92 | -48.49% |
| 2007 | -7.61 | -82.6% |
| 2006 | -43.8 | 321.62% |
| 2005 | -10.4 | -5.49% |
| 2004 | -11.0 | -160.19% |
| 2003 | 18.2 | -83.54% |
| 2002 | 111 | -236.31% |
| 2001 | -81.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 34.7 | -76,617,828.23% | 🇺🇸 USA |
 | -12.6 | 27,707,152.46% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.